Charles River Laboratories International, Inc. (CRL)
305.06
-5.70
(-1.84%)
USD |
NYSE |
Oct 06, 16:00
305.06
0.00 (0.00%)
After-Hours: 20:00
Charles River Laboratories International Cash from Investing (Quarterly) : 28.10M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.10M |
| March 31, 2026 | -407.84M |
| December 31, 2025 | -73.67M |
| September 30, 2025 | -33.70M |
| June 30, 2025 | -37.34M |
| March 31, 2025 | -64.62M |
| December 31, 2024 | -76.10M |
| September 30, 2024 | -21.32M |
| June 30, 2024 | -61.87M |
| March 31, 2024 | -85.79M |
| December 31, 2023 | -238.37M |
| September 30, 2023 | -79.56M |
| June 30, 2023 | -76.61M |
| March 31, 2023 | -168.62M |
| December 31, 2022 | 44.38M |
| September 30, 2022 | -92.19M |
| June 30, 2022 | -462.11M |
| March 31, 2022 | -98.00M |
| December 31, 2021 | 9.307M |
| September 30, 2021 | -355.05M |
| June 30, 2021 | -954.19M |
| March 31, 2021 | -138.00M |
| December 31, 2020 | -88.42M |
| September 30, 2020 | -70.81M |
| June 30, 2020 | -28.63M |
| Date | Value |
|---|---|
| March 31, 2020 | -413.68M |
| December 31, 2019 | -70.87M |
| September 30, 2019 | -61.39M |
| June 30, 2019 | -528.42M |
| March 31, 2019 | -20.81M |
| December 31, 2018 | -70.96M |
| September 30, 2018 | -33.02M |
| June 30, 2018 | -829.47M |
| March 31, 2018 | -25.30M |
| December 31, 2017 | -33.15M |
| September 30, 2017 | -54.28M |
| June 30, 2017 | -39.49M |
| March 31, 2017 | 52.52M |
| December 31, 2016 | -71.56M |
| September 30, 2016 | -11.31M |
| June 30, 2016 | -598.63M |
| March 31, 2016 | -6.931M |
| December 31, 2015 | -71.92M |
| September 30, 2015 | -212.83M |
| June 30, 2015 | -24.81M |
| March 31, 2015 | -12.61M |
| December 31, 2014 | -81.31M |
| September 30, 2014 | -14.57M |
| June 30, 2014 | -196.01M |
| March 31, 2014 | -7.175M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | -381.00M |
| Medpace Holdings, Inc. | -23.88M |
| Fortrea Holdings, Inc. | -7.00M |
| Champions Oncology, Inc. | -0.055M |
| Avantor, Inc. | -37.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 179.72M |
| Cash from Financing (Quarterly) | -164.66M |
| Free Cash Flow | 370.60M |
| Free Cash Flow Per Share (Quarterly) | 3.095 |
| Free Cash Flow to Equity (Quarterly) | 178.83M |
| Free Cash Flow to Firm (Quarterly) | 148.19M |
| Free Cash Flow Yield | 2.48% |